華虹半導體(01347.HK)升12.6%曾創逾兩月高 A股發行申請獲受理
華虹半導體(01347.HK)今日高開6.7%,報21元後,最高見23.05元,創逾兩個月高。現報22.15元,升12.55%,成交2,392.5萬股,涉資5.3億元。
華虹半導體公布,近期收到上海證券交易所就公司提交的人民幣股份發行申請出具的受理單。招股書披露,公司擬首次公開發行不超過4.33億股A股,並於上交所科創板上市。預計集資淨額180億人民幣,擬用於華虹製造(無錫)項目、8英吋廠優化升級項目、特色工藝技術創新研發項目及補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.